94 filings
Page 4 of 5
DEF 14A
5e3rwjb4xq 0tl6
19 Oct 15
Definitive proxy
12:00am
PRE 14A
u4rmg fqk
2 Oct 15
Preliminary proxy
12:00am
8-K
7pae658ho8e2jo1o
17 Sep 15
Nexvet Secures Biomanufacturing Facility and Receives IDA Ireland Support
12:00am
8-K
l1hlugz qkfoo
3 Sep 15
Nexvet Biopharma Reports Full Year Fiscal 2015 Results
12:00am
10-K
xx54e1deuq 6s8g4
3 Sep 15
Annual report
12:00am
8-K
6w1jk1je48 cyry3czmz
2 Jul 15
Departure of Directors or Certain Officers
12:00am
8-K
e071fj1d
8 Jun 15
Nexvet Advances Manufacturing Strategy
12:00am
8-K
rsc i5m3ldgr
4 Jun 15
Nexvet Announces Positive Top-Line Results for Proof-of-Concept Efficacy Study of NV-02 in Cats with Degenerative Joint Disease
12:00am
8-K
kj3vcdax2jubauf 2r
11 May 15
Nexvet Appoints Dr. Jürgen Horn as Chief Product Development Officer
12:00am
8-K
7z3uje5u z6kj02eo
8 May 15
Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2015
12:00am
8-K
ulu4la4annpm4z
16 Apr 15
Nexvet Provides Update on NV-01 Program
12:00am
8-K
2ycx7op8xbzpww1xr 48
1 Apr 15
Nexvet Biopharma Appoints Dr. George Gunn as Chairman
12:00am
S-8
am32xzt6 vh6xfp
25 Mar 15
Registration of securities for employees
12:00am
10-Q
s3zsm0kgaj hery7r
13 Mar 15
Quarterly report
12:00am
8-K
5cpzb j1myq0
13 Mar 15
Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2015
12:00am
8-K
79phfipew3x9 89q4
9 Mar 15
Nexvet Provides Update on Pivotal Field Safety and Efficacy Study for NV-01
12:00am
CT ORDER
pneo46jni6dp42se6
6 Feb 15
Confidential treatment order
12:00am
424B4
vfcdw
5 Feb 15
Prospectus supplement with pricing info
12:00am